AI-powered search
Try Polaris, our new AI-powered search!

How concerned are you about the risk of death mentioned in the boxed warning for ruxolitinib cream?

Featuring Matthew Zirwas, MD |

Associate Professor of Dermatology 
Ohio University Heritage College of Medicine 
Athens, OH

| Published November 17, 2021

More from this series

Who is a good candidate for lebrikizumab?

Atopic Dermatitis

Who is a good candidate for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for lebrikizumab?

Atopic Dermatitis

What is the dosing regimen for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the safety profile of lebrikizumab?

Atopic Dermatitis

What is the safety profile of lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI